New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on biomedical science and clinical practice.
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021年2月10日 · Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg …
Toxic Effects from Ivermectin Use Associated with Prevention and ...
2021年10月20日 · The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin …
Coronavirus (Covid-19) | NEJM
2024年7月17日 · Explore a collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2020年12月10日 · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a …
Tirzepatide versus Semaglutide Once Weekly in Patients with Type …
2021年6月25日 · Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the treatment …
Dapagliflozin in Patients with Chronic Kidney Disease - The New …
2020年9月24日 · Patients with chronic kidney disease have a high risk of adverse kidney and cardiovascular outcomes. The effect of dapagliflozin in patients with chronic kidney disease, …
Biologic Therapies for Severe Asthma - The New England Journal …
2022年1月12日 · Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the …
Current Issue - The New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 392 No. 4).